Supernus Pharmaceuticals (SUPN) Q2 2022 Earnings

13AprConfirmed
Q2 2021
Q3 2021
Q4 2021
Q2 2022
0.04
0.17
0.3
0.43

Details

Expected EPS
0.29
Actual EPS
0.04
Surprise EPS
-0.25
Surprise Percent
+86.21%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.04 per share for Q2 2022.

0 Comments

Share your thoughts